Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sulphasalazine measurement |
Component |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulphasalazine adverse reaction |
Causative agent (attribute) |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine allergy |
Causative agent (attribute) |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfasalazine [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfasalazine 50 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfasalazine 3g/100mL retention enema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfasalazine [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfasalazine 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfasalazine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfasalazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine allergy |
Causative agent (attribute) |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine allergy |
Causative agent (attribute) |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Sulfasalazine therapy (procedure) |
Direct substance |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfasalazine 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfasalazine 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine 500mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) |
Has precise active ingredient |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfasalazine 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine 50 mg/mL oral suspension |
Has basis of strength substance (attribute) |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine 50 mg/mL oral suspension |
Has precise active ingredient |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sulfasalazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sulfasalazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine 30 mg/mL rectal suspension |
Has precise active ingredient |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sulfasalazine 30 mg/mL rectal suspension |
Has basis of strength substance (attribute) |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfasalazine 1 gram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sulfasalazine 1 gram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sulfasalazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |